193 related articles for article (PubMed ID: 10632082)
1. Kappa-opioid receptors behind the blood-brain barrier are involved in the anti-hypertensive effects of systemically administered kappa-agonists in the conscious spontaneously hypertensive rat.
Shen S; Ingenito AJ
J Pharm Pharmacol; 1999 Nov; 51(11):1251-6. PubMed ID: 10632082
[TBL] [Abstract][Full Text] [Related]
2. Sustained antihypertensive effects of chronic administration of two kappa-opioid agonists in spontaneously hypertensive rats.
Zhai QZ; Ingenito AJ
Am J Ther; 1997; 4(5-6):173-80. PubMed ID: 10423608
[TBL] [Abstract][Full Text] [Related]
3. Depressor effect of kappa opioid agonist on hypertension induced by isolation in the rat.
Shen S; Ingenito AJ
Clin Exp Hypertens; 1999 Apr; 21(3):275-97. PubMed ID: 10225482
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats.
Zaratin P; Clarke GD
Eur J Pharmacol; 1994 Oct; 264(2):151-6. PubMed ID: 7851477
[TBL] [Abstract][Full Text] [Related]
5. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
Brooks DP; Giardina G; Gellai M; Dondio G; Edwards RM; Petrone G; DePalma PD; Sbacchi M; Jugus M; Misiano P
J Pharmacol Exp Ther; 1993 Jul; 266(1):164-71. PubMed ID: 8392549
[TBL] [Abstract][Full Text] [Related]
6. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
Zhai QZ; Ingenito AJ
J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
[TBL] [Abstract][Full Text] [Related]
7. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
Wang YX; Clarke GD; Sbacchi M; Petrone G; Brooks DP
J Pharmacol Exp Ther; 1994 Jul; 270(1):244-9. PubMed ID: 8035321
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of intrahippocampal injection of dynorphin A(1-8), dynorphin A(1-13), dynorphin A(1-17), U-50,488H, and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Wang JQ; Ingenito AJ
Peptides; 1994 Jan; 15(1):125-32. PubMed ID: 7912425
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in the hypotensive effect of a kappa-opioid receptor agonist in hypertensive rats.
Guo HT; Zhang RH; Huang LY; Li J; Liu YL; Bi H; Zhang QY; Wang YM; Sun X; Ma XL; Cheng L; Liu JC; Yu SQ; Yi DH; Pei JM
Arch Med Res; 2007 Oct; 38(7):723-9. PubMed ID: 17845890
[TBL] [Abstract][Full Text] [Related]
10. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
11. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
12. Effects of rat brain kappa 1- and kappa 2-opioid receptors after chronic treatment with non-peptide kappa-agonists.
McConnaughey MM; Zhai QZ; Ingenito AJ
J Pharm Pharmacol; 1998 Oct; 50(10):1121-5. PubMed ID: 9821658
[TBL] [Abstract][Full Text] [Related]
13. Chronic blockade of hippocampal kappa receptors increases arterial pressure in conscious spontaneously hypertensive rats but not in normotensive Wistar Kyoto rats.
Shen S; Ingenito AJ
Clin Exp Hypertens; 2000 Jul; 22(5):507-19. PubMed ID: 10937841
[TBL] [Abstract][Full Text] [Related]
14. Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats.
Sun SY; Liu Z; Li P; Ingenito AJ
Gen Pharmacol; 1996 Oct; 27(7):1187-94. PubMed ID: 8981066
[TBL] [Abstract][Full Text] [Related]
15. Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats.
Chaouche-Teyara K; Lacolley P; Challande P; Fournier B; Laurent S; Safar M; Dabiré H
J Cardiovasc Pharmacol; 1997 Aug; 30(2):241-4. PubMed ID: 9269953
[TBL] [Abstract][Full Text] [Related]
16. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats.
Kawano Y; Yoshida K; Matsuoka H; Omae T
Am J Hypertens; 1994 Jun; 7(6):536-42. PubMed ID: 7917152
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effect of chronic i.v. administration of 5-carboxamidotryptamine in spontaneously hypertensive rats.
Balasubramaniam G; Lee HS; Mah SC
Eur J Pharmacol; 1993 Jun; 237(2-3):207-13. PubMed ID: 8365451
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats.
Yu XC; Wang HX; Zhang WM; Wong TM
J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
